Forte Biosciences, Inc.

Nasdaq:FBRX

Pharmaceutical Preparations·DALLAS, TX

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/28/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

23 shown

Filed	Period
11/14/25	Q4 FY2025	→
8/14/25	Q3 FY2025	→
5/15/25	Q2 FY2025	→
4/4/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
8/14/24	Q3 FY2024	→
↓

News (8-K)

57 shown

Filed	Type	Description
6/25/25	Agreement	Entry into a Material Definitive Agreement	→
6/23/25	Reg FD	Regulation FD Disclosure	→
5/30/25	Vote	Submission of Matters to a Vote of Security Holders	→
4/18/25	Other	Other Events	→
1/24/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/3/24	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
9/30/25	S-8	S-8	→
6/25/25	424B5	424B5	→
6/24/25	424B5	424B5	→
4/30/25	ARS	ARS	→
3/28/25	S-3	S-3	→
2/7/25	S-8	S-8	→
↓

Filing History(582 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 17, 2026

0001274173-26-000094

—

12.3 KB

SCHEDULE 13G/A

Jan 29, 2026

0001315863-26-000097

—

15.2 KB

SCHEDULE 13G

Jan 20, 2026

0000902664-26-000316

—

17.3 KB

Jan 13, 2026

0001339375-26-000004

Jan 12, 2026

8.6 KB

Jan 13, 2026

0001612842-26-000004

Jan 12, 2026

8.5 KB

SCHEDULE 13G/A

Jan 9, 2026

0001376474-26-000030

—

7.3 KB

Jan 2, 2026

0001612842-26-000002

Jan 1, 2026

9.1 KB

Jan 2, 2026

0001339375-26-000002

Dec 30, 2025

11.1 KB

SCHEDULE 13G

Dec 23, 2025

0001315863-25-000873

—

13.4 KB

SCHEDULE 13G/A

Nov 14, 2025

0000921895-25-003098

—

22.3 KB

SCHEDULE 13G/A

Nov 14, 2025

0001193125-25-282840

—

99.6 KB

10-Q

Nov 14, 2025

0001193125-25-28180810-Q

Sep 30, 2025

7.4 MB

8-K

Nov 14, 2025

0001193125-25-2818078-K

Nov 14, 2025

206.7 KB

SCHEDULE 13G/A

Oct 7, 2025

0001623632-25-001387

—

44.2 KB

Oct 2, 2025

0001339375-25-000003

Oct 1, 2025

8.9 KB

Oct 2, 2025

0001612842-25-000003

Oct 1, 2025

8.8 KB

S-8

Sep 30, 2025

0001193125-25-225010S-8

—

197.6 KB

SCHEDULE 13G/A

Sep 5, 2025

0001623632-25-001195

—

44.2 KB

SCHEDULE 13G/A

Aug 14, 2025

0000950170-25-108951

—

87.0 KB

SCHEDULE 13G/A

Aug 14, 2025

0000950170-25-108914

—

13.4 KB

10-Q

Aug 14, 2025

0000950170-25-10888910-Q

Jun 30, 2025

7.2 MB

8-K

Aug 14, 2025

0001193125-25-1807718-K

Aug 14, 2025

18.8 MB

SCHEDULE 13G/A

Aug 14, 2025

0001274173-25-000248

—

10.5 KB

SCHEDULE 13G/A

Aug 7, 2025

0001549230-25-000022

—

15.4 KB

SCHEDULE 13G/A

Aug 4, 2025

0000929638-25-002878

—

14.0 KB

25 filings shown

Filed	Form	Description
4/30/25	DEF 14A	DEF 14A	→
12/31/24	DEF 14A	DEF 14A	→
7/30/24	DEF 14A	DEF 14A	→
7/19/24	PRE 14A	PRE 14A	→
9/1/23	DEFA14A	DEFA14A	→
8/31/23	DEFA14A	DEFA14A	→
↓

Forte Biosciences, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(582 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/13/26	4	4	→
1/13/26	4	4	→
1/2/26	4	4	→
1/2/26	4	4	→
10/2/25	4	4	→
10/2/25	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/29/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/20/26	SCHEDULE 13G	SCHEDULE 13G	→
1/9/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/23/25	SCHEDULE 13G	SCHEDULE 13G	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓